Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Post-approval studies (Phase 4)WithdrawnNCT02346630
What this trial is testing

Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation

Who this might be right for
Stroke
Ross D. Zafonte, MD
Not applicableStudy completedNCT07262099
What this trial is testing

Study of Effects of Dao-yin Exercise on the Patients With Breast Cancer Post Operation and Receiving Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Tri-Service General Hospital (TSGH) 150
Not applicableStudy completedNCT06280612
What this trial is testing

The Effect of Live Cat and Simulation Cat Therapies on Oncology Patients

Who this might be right for
Therapy-Associated CancerCancer PatientHappiness+1 more
Karadeniz Technical University 45
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Testing effectiveness (Phase 2)Study completedNCT00736944
What this trial is testing

Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Washington University School of Medicine 30
Not applicableLooking for participantsNCT06858449
What this trial is testing

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
CancerBreast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 30
Testing effectiveness (Phase 2)WithdrawnNCT05687721
What this trial is testing

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Who this might be right for
Advanced Urothelial Carcinoma
VA Office of Research and Development
Not applicableNo Longer AvailableNCT06195514
What this trial is testing

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Takeda
Testing effectiveness (Phase 2)Active Not RecruitingNCT04214249
What this trial is testing

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT01731548
What this trial is testing

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

Who this might be right for
Carcinoma of LungSmall CellLimited Stage
Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)WithdrawnNCT03175666
What this trial is testing

QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc.
Large-scale testing (Phase 3)UnknownNCT02648841
What this trial is testing

Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

Who this might be right for
Gastric Cancer
Chinese Academy of Medical Sciences 588
Large-scale testing (Phase 3)Study completedNCT00805194
What this trial is testing

LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,314
Not applicableStudy completedNCT00336102
What this trial is testing

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Who this might be right for
Breast CancerFatigueHypothyroidism
University of South Florida 541
Large-scale testing (Phase 3)Ended earlyNCT00005983
What this trial is testing

S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 98
Early research (Phase 1)Study completedNCT05544227
What this trial is testing

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Williams Cancer Foundation 15
Not applicableLooking for participantsNCT05552846
What this trial is testing

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Who this might be right for
Small-cell Lung Cancer
Ruijin Hospital 104
Testing effectiveness (Phase 2)Ended earlyNCT04016142
What this trial is testing

Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced CancerCervical Cancer
Centre Oscar Lambret 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Next Page
49